Table 2.

Patient, graft characteristics at transplant, and hematopoietic recovery

Characteristic	No. Patients
Total patients	102
Median age at transplant (range)	44 (19-65) years
Hodgkin's and non-Hodgkin's	61
Median months to SCT (range)	18 (8-140)
Median lines prior therapy (range)	3 (1-6)
Disease status at transplant
Complete remission 2	13
Sensitive relapse	36
Refractory relapse	12
Multiple Myeloma	41
Median months to SCT (range)	8 (3-116)
Median lines prior therapy (range)*	2 (1-6)
Disease status at transplant
Persistent disease, chemo-sensitive	34
Persistent disease, chemo-refractory	7
Stem Cell Source
Bone marrow	4
Peripheral blood	98
Graft Composition, median (range)
Total nucleated cells (×108/kg)	6.5 (1.6-33.9)
CD34+ (×106/kg)	5.2 (0.7-12.5)
Days to ANC >0.5 ×109/L, median (range)	10 (8-44)
Days to Platelet >20 ×109/L, median (range)	9 (7-141)

^*2 prior autologous SCT